hesperetin has been researched along with Cardiotoxicity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Eltelbany, RFA; Khalil, HMA; Rasheed, RA; Zaafar, D; Zaitone, SA | 1 |
Chang, J; Li, F; Li, X; Yan, A; Zhu, J | 1 |
2 other study(ies) available for hesperetin and Cardiotoxicity
Article | Year |
---|---|
Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway.
Topics: Animals; Cardiotoxicity; Hesperidin; Interleukin-6; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Sorafenib; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
[Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
Topics: Apoptosis; Cardiotoxicity; Caspase 3; Cytochromes c; Doxorubicin; Humans; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Sirtuin 1; Superoxide Dismutase | 2023 |